Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice.
Liu M, Bryant MS, Chen J, Lee S, Yaremko B, Li Z, Dell J, Lipari P, Malkowski M, Prioli N, Rossman RR, Korfmacher WA, Nomeir AA, Lin CC, Mallams AK, Doll RJ, Catino JJ, Girijavallabhan VM, Kirschmeier P, Bishop WR.
Liu M, et al. Among authors: nomeir aa.
Cancer Chemother Pharmacol. 1999;43(1):50-8. doi: 10.1007/s002800050862.
Cancer Chemother Pharmacol. 1999.
PMID: 9923541